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The transcription factor, nuclear factor kappa B (NF-kB) is one of the principal inducible protein in mammals known to control 
the gene expression in many critical physiological responses such as oxidative stress, inflammation etc. and has been shown to play 
an important role in the pathogenesis of cancer. Terpenoids are major constituents present in nutritionally used fruits, vegetables 
and different spices which possess various pharmacological action including anticancer activity. Various terpenoids, viz. monoter-
penoids, sesquiterpenoids, diterpenoids, sesterterpenoids, triterpenoids, tetraterpenoids and polyterpenoids inhibit NF-kB signa-
ling pathway through IkB phosphorylation, DNA binding, p65 translocation etc. Keeping in mind these facts, the present review 
revealed the anti-cancer potential of naturally occurring terpenoids highlighting their mechanism of NF-kB inhibition. This review 
also focuses on some of the naturally occurring terpenoids belonging to various chemical categories with potential inhibitory effects 
on NF-kB and their role in the treatment of cancer.
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Nuclear factor kappa B (NF-κB) is one of the most 
important transcription factors in mammals which is re-
sponsible for controlling gene expression linked with 
physiological responses, viz. oxidative stress, inflam-
mation etc., and has been shown to play a pivotal role 
in the mechanism of cancer development. Therefore, 
the signaling pathway involving this transcriptional fac-
tor has opened a new way for pharmacologists, mainly 
in the field of oncology, where this pathway could prove 
to be of utmost importance in the treatment of cancer [1].
Naturally occurring plant components from tra-
ditional herbs are a significant source of potential 
therapeutic compounds for cancer treatment. Today 
seve ral drugs used in clinics are discovered from 
natural sources. Safety and toxicity of modern drugs 
are very often questionable. Because of this appre-
hension, there is tremendous increase in the interest 
in natural medicines that are considered to be safe. 
Active constituents such as phenolic, flavonoids, gly-
cosides and alkaloids of plants are well known for their 
medicinal values [2, 3]. Plant derived natural products 
provide a source for potent molecules to combat 
many diseases including cancer. Several promising 
molecules have been identified as anticancer agents, 
but there are still hurdles to overcome before they can 
be accepted as modern drugs [4].
Phenolic compounds and terpenoids are major 
constituents present in nutritionally used fruits, vege-
tables and different spices which possess various 
pharmacological activities including anticancer activity. 
Reports revealed that terpenoids that contain variable 
isoprene units have shown potential anticancer acti-
vity. Many of terpenoids which are extensively used for 
medical purpose have already been studied. Previous 
reports revealed that natural terpenoids were found 
to have cytotoxicity against variety of tumor cells. This 
observation strongly suggests that plant derived thera-
peutic ingredients modulate NF-κB signaling, which 
has a major role in the pathogenesis of cancer [5–8].
The present review focuses on the anticancer 
potential of natural terpenoids of varied categories, 
viz. monoterpenoids, sesquiterpenoids, diterpenoids, 
sesterterpenoids, triterpenoids, tetraterpenoids and 
polyterpenoids as NF-κB inhibitors. The review also 
deals with the activation and inhibition mechanism 
of NF-κB signaling pathways.
structure, functIon 
and regulatIon of nf-κB
NF-κB protein comprises of homodimers and hete-
rodimers of different subunits. NF-κB is related through 
deoxyribonucleic acid (DNA) binding domain called 
as Rel homology domain. NF-κB proteins belonging 
to Rel family consists of five members which includes: 
p65 (RelA), RelB, cRel, p50/p105 (NF-κB 1) and p52/
p100 (NF-κB 2). NF-κB 1 and NF-κB 2 are synthesized 
as precursor p100 and p105. Rel or NF-κB transcrip-
tion factor binds to 9–10 base pair DNA sites known 
as kB sites. All vertebrate Rel proteins can form ho-
modimers or heterodimers, except RelB that can form 
only heterodimers [9–11].
Rel or NF-κB proteins can be divided into two class-
es based on the sequence C-terminal to RH domain. 
Members of one class have long C-terminal which 
contains multiple copies of ankyrin repeats (33 residue 
protein structure) and has transrepression activity. 
This class includes NF-κB proteins p105, p100, and 
Drosophila Relish. The second class (the Rel proteins) 
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includes c-Rel (and its retroviral homologue v-Rel), 
RelB, RelA (p65). This second class of Rel proteins 
contains C-terminal transcription activation domains 
which is required for transport of active NF-κB complex 
into the nucleus. The subunits p50 and p52 do not 
contain transcription activation domain [12, 13].
The transcriptional activity of NF-κB is suppressed 
by interaction with IκB family of inhibitory proteins. 
Nuclear factor of kappa light polypeptide gene en-
hancer in B-cells inhibitor (IκB) proteins are family 
of related proteins containing six or more ankyrin units 
at their N-terminus. IκB proteins include the following 
members: IκBα, IκBβ, IκBγ, IκBε, Bcl-3, Cactus, and 
the precursor proteins p100, p105 which contains five 
to seven ankyrin repeats [14].
sIgnalIng pathway of nf-κB
Activation of NF-κB. Two signaling pathways lead 
to the activation of NF-κB, known as the classical (canoni-
cal) pathway and the alternative (non-canonical) path-
way. The common regulatory step in both of these path-
ways is activation of an enzyme IκB kinase (IKK) which 
is present in complex form that consist of catalytic kinase 
subunits (IKKα/IKKβ) and the regulatory non-enzymatic 
protein NF-κB essential modulator (NEMO) also known 
as IKKγ. Activation of NF-κB dimers due to IKK involves 
phosphorylation which leads to proteasomal degrada-
tion of IκB, enabling the active NF-κB transcription factor 
for cytoplasmic translocation into the nucleus, thereby 
inducing target gene expression [14].
In the classical or canonical pathway proinflamma-
tory cytokine tumor necrosis factor α (TNFα) stimulates 
and activates NF-κB, which in turns activates the sub-
unit of IKK complex and leads to phosphorylation and 
degradation of IκB inhibitors. The canonical pathway 
activates NF-κB dimers comprising of RelA, c-Rel, RelB 
and p50. This pathway plays major role in the control 
of innate immunity and inflammation (Fig. 1) [15, 16].
p100/Re1B complexes are activated by non-
canonical pathway and this pathway seems to involve 
an IKK complex consisting of two IKKα subunits 
(Fig. 2). Non-canonical pathway works on the mecha-
nism of ligand induced activation which results in the 
activation of central signaling component of the path-
way, i.e., NF-κB-inducing kinase (NIK). NIK phos-
phorylates and activates a downstream kinase, IκB 
kinase-α (IKKα) which further phosphorylates p100. 
Phosphorylation of p100 causes the translocation 
of NF-κB to the nucleus, which subsequently binds 
to specific target genes for processing [17].
Inhibition of NF-κB. In inactivated form, NF-κB re-
mains in cytoplasm by family of inhibitors known as IκB 
proteins. This protein contains ankyrin repeats and 
masks the nuclear localization signals of NF-κB pro-
teins and makes them inactivated and remains in the 
cytoplasm.
IKK complex consist of three subunits, IKKα, IKKβ, 
IKKγ also known as NEMO. IKKα plays an important role 
in NF-κB regulation, and also in epidermal diffe rentiation 
independent of NF-κB pathway. IKKβ plays important 
function in the phosphorylation. NEMO is also known 
as inhibitor of IKKγ and this activates NF-κB [18, 19].
fig. 1. Canonical pathway of NF-κB signaling
fig. 2. Non-canonical pathway of NF-κB signaling
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mechanIsm of nf-κB actIon 
In malIgnant transformatIon
It was found that inactive NF-κB dimers are lo-
cated in cell cytoplasm and are unable to bind with 
DNA as this inhibition of binding is associated with 
IκB proteins. This IκB proteins form complex with 
NF-κB. IκBα or IκBβ proteins of IκB family, selectively 
bind to the p50/p65 heterodimers and masks their 
nuclear localization signal, preventing nuclear trans-
location of NF-κB. Activation of NF-κB can occur 
by acetylation of p65 (RelA). Acetylated NF-κB is ac-
tive and resistant from inhibitory action of IκB protein. 
Activation of NF-κB requires phosphorylation of IκB 
proteins by external inducers which activate enzyme 
IKK. This IKK phosphorylates the IκB protein result-
ing in dissociation of NF-κB from IκB protein and 
degradation of IκB by proteasome. The enzyme IKK 
is composed of heterodimers of catalytic IKKα and 
IKKβ and a regulatory protein NEMO. The NF-κB is then 
translocated to nucleus to activate target genes. The 
DNA/NF-κB complex then recruits other proteins that 
transcribe DNA into mRNA and then translate into pro-
teins which result in change in cell function and may 
cause cancer (Fig. 3) [1–3, 13, 14].
fig. 3. Inhibition by different terpenoids in NF-κB signaling 
pathways (Ub — ubiquitination; P — phosphorylation)
terpenoIds:  
chemIstry and synthesIs
Origination of term terpene came from word tur-
pentine (lat. Balsamum terebinthinae). Terpenes are 
a large and varied class of natural products, produced 
primarily by a wide variety of plants, insects, microor-
ganisms, and animals. More than 55,000 terpenoid 
molecules have been discovered so far. Diffe rent 
chemical and biological studies have proved that 
terpenoids possess variety of chemical, physical and 
biological activities due to their rich diversity in struc-
tural classes with varying degrees of unsaturation, 
functional groups, and ring closures [20].
Chemistry of terpenoids. Terpenoids are formed 
by 2-methylbutane residues, less precisely but usually 
also referred to as isoprene units (C5H8) and called 
as isoprenoids known to build up the carbon skeleton 
of terpenes. Terpenoids are broadly classified on the 
basis of the number of isoprene units present in the 
molecule. Depending on the number of 2-methylbu-
tane (isoprene) subunits one differentiates between 
hemi- (C5), mono- (C10), sesqui- (C15), di- (C20), sester- 
(C25), tri- (C30), tetraterpenes (C40) and polyterpenes 
(C5)n with n > 8 [20].
Biosynthesis of terpenoids. Terpenoids are 
the secondary metabolites obtained naturally; these 
terpenoids are synthesized from isopentyl pyrophos-
phate  and its isomer dimethylallyl pyrophosphate. 
Synthesis of terpenoids involves an enzyme known 
as terpene synthase. During the synthesis, firstly 
geranyl pyrophosphate, farnesyl pyrophosphate, 
geranylgeranyl pyrophosphate are synthesized. The 
prenyl pyrophosphate acts as precursor for different 
terpenoids such as monoterpenoids, diterpenoids, 
sesqueterpenoids. In triterpenoid synthesis oxido-
squalene cyclase converts oxidosqualene into cyclic 
triterpene alcohols. Tetraterpenoids are synthesized 
from phytoene pathway in which phytoene synthases 
catalyzes the conversion of geranylgeranyl pyrophos-
phate into phytoene via condensation [21–23].
natural terpenoIds 
as nf-κB sIgnalIng InhIBItors
Terpenoids of natural origin can inhibit the signa ling 
of NF-κB, the major regulator in the pathogenesis of in-
flammation and cancer. Various pathways were found 
to be involved in the anticancer activity of terpenoids, 
including activation of apoptosis. The terpenoids from 
natural sources are well known inhibitors of NF-κB sig-
naling (Fig. 3). Some therapeutic indications on various 
terpenoids are described in the subsequent section.
Monoterpenoids. Monoterpenes (Table 1) are 
composed of isoprene units (two in number) with 
a general molecular formula of C10H16. They exist 
in acyclic, monocyclic or bicyclic forms. Naturally, 
monoterpenoids are found as terpene derivatives 
and modifications resulting from oxidation, methyla-
tion and glycosylation and most of them are volatile 
in nature [21, 22]. Some of the monoterpenoids act 
as NF-κB signaling inhibitors through IκB degradation, 
DNA binding or p65 translocation [24–26]. Some of the 
monoterpenoids are described below.
Aucubin. The glycoside derivatives irinoids are 
a class of monoterpenoids. The most common irinoid 
glycoside is aucubin. According to some studies, IκBα 
degradation is prevented by aucubin. Aucubin also 
prevents the nuclear translocation of p65 subunit 
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of NF-κB complex in stimulated mast cells. It has been 
revealed through different studies that aucubin could 
be useful agent in prevention of inflammation, cancer, 
and hepatotoxicity [24–26].
Limonene. Limonenes are cyclic aromatic mono-
terpenes. The derivatives of limonene are perillic 
acid, perillyl alcohol and menthol. It has observed 
that menthol and perillyl alcohol have ability to induce 
NF-κB dependent apoptosis. In lymphoma cells, these 
compounds may inhibit NF-κB signaling. Also, in some 
studies the capability of limonene and perillyl alcohols 
to inhibit proliferation and metastasis of gastric can-
cer has been revealed; also it has been shown that 
dietary monoterpenes, limonene and perillyl alcohols 
have an inhibitory effect on mammary and pancreatic 
tumors in animal models [27–29].
α-Pinene. Pinene, a bicyclic monoterpene, 
is a powerful inhibitor of NF-κB system and is usually 
obtained from conifer trees. It has been reported that 
α-pinene inhibit NF-κB/p65 protein translocation in li-
popolysaccharide (LPS) stimulated THP-1 cells. The 
inhibition of NF-κB signaling increased the expression 
of IκBα protein in the cells pretreated with α-pinene. 
It could be inferred from the studies that NF-κB signal-
ing is inhibited by several flavoring monoterpenoids 
which are found in essential oils and spices. These 
flavoring monoterpenoids can also be used in inflam-
matory diseases and cancer [30].
Catalposide. Catalposide is an iridoid glycoside 
that inhibit NF-κB system. Catalposide inhibit degrada-
tion of IκBα protein and also translocation of p65 sub-
unit [31].
Genipin. Genipin is a monoterpenoid that inhibit 
degradation of IκBβ protein thus inhibiting NF-κB sig-
naling. Genipin is the metabolite product of genipino-
side. Genipin inhibits the expression of iNOS and 
NO production in LPS stimulated cells [24, 32].
Sesquiterpene. Sesquiterpenes (Table 2) are 
derived from three isoprene units. Hence, they are 
C13 compounds and biosynthesized from farnesyl 
pyrophosphate. They have wide occurrence in nature 
and are mainly found in plants and fungi. The carbon 
skeleton of sesquiterpenes is found in highly diverse 
forms as compared to other terpenes. Sesquiterpene 
lactones contain α-methylene, γ-lactone system. Some 
of them also contain α-β-unsaturated carbonyls and 
epoxides. A number of sesquiterpene lactones show 
antitumor properties [32, 33].
Costunolide. Costunolide is a sesquiterpene lac-
tone and a popular folk remedy in India. The most 
common source of costunolide is the root of medicinal 
plant Saussurea costus and it is also isolated from 
other medicinal plants such as Magnolia grandiflora. 
The mechanism of inhibition of NF-κB signaling by co-
sutnolide is the prevention of phosphorylation of IκB 
proteins. It also inhibits LPS induced basic inflamma-
tory signaling pathway by inhibition of NF-κB activation 
and by prevention of downstream gene expression. 
Though some studies have presented it as an agent 
having anticancer, anti-inflammatory, anti-microbial, 
anti-ulcer properties but still these effects need more 
verification [34–37].
Artemisinin. Artemisinin, a sesquiterpene lac-
tone, is a traditional Chinese medicine and is also 
called qinghaosu. Artemisinin is obtained from leaves 
Table 1. Natural monoterpenoids as inhibitors of NF-κB pathways
Name Structure Site of NF-κB inhibition Therapeutic Indication References
Aucubin
O
OH
H
H
RO
H
HO
H
IκBα degradation Inflammation, hepatotoxic-ity, cancer [24–26]
Limonene CH3
H2C
H3C
DNA binding Lymphoma and metastasis of gastric cancer [27–29]
α-Pinene
H3C
H3C
CH3
P65 translocation Inflammation [30]
Catalposide
O
O
OHO H
O
H
O
OH
HO
HO
HO
OH
H
O
IκBα degradation Inflammation [31, 32]
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of Artemisia annua. Artemisinin is very popular for 
the treatment of multidrug resistant malaria. Some 
stu dies have revealed its anticancer, immunosuppres-
sive, anti-fungal and anti-angiogenesis properties. 
Chemically, artemisinin is endoperoxide sesquiter-
penoid lactone containing complex polycyclic rings 
which function through alkylation of protein (a typical 
mechanism of sesquiterpene lactones). In cells, there 
Table 2. Natural sesquiterpenes as inhibitors of NF-κB pathways
Name Structure Site of NF-κB inhibition Therapeutic Indication References
Costunolide
O
H3C
H3C
O
CH2
H
H
IκB phosphorylation Leukemia, inflammation [33–35]
Artemisinin O
O
O
O O
H
CH3
H
H
H3C
CH3
DNA binding Malaria, cancer [36–38]
Humulene
H3C
CH3
H3C
CH3
DNA binding Inflammation [40]
Parthenolide
O
O
O
CH2 Alkylation of p65 Arthiritis, lung cancer [33, 59–61]
Helenalin A
O
O CH2
O
H
H
OH
H3C
H
CH3
p65 alkylation Inflammation, infection [62, 63]
Ergolide
O
O
H H
3HC
H
O
AcO
H3C
IκB degradation Inflammation, cancer [64, 65]
Zerumbone
H3C
H3C
O
CH3
CH3
IκBα degradation Inflammation, metastasis [66, 67]
Valerenic 
acid
CH3
HO O
H3C
H
CH3
Reporter assay Insomnia [68]
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are many targets for alkylation, even NF-κB transcrip-
tion system may be one, as artemisinin inhibits acti-
vation of NF-κB signaling induced by LPS. In a study 
of TNFα treated human synoviocytes, it was found that 
a synthetic derivative of artemisinin, artesunate, inhi-
bited NF-κB signaling activation and proinflammatory 
cytokines production. Though the exact mechanism 
of artemisinin is unclear, but still it is an important 
agent as DNA binding of NF-κB complex which has 
been reported in some studies [38–40].
Nepalolide A. A plant of Chinese traditional medicine 
Carpesium nepalense is a source of sesquiterpene 
lactone nepalolide A. In C6 glioma cells, nepalolide 
A is found to suppress signaling induced by LPS and 
cytokine and inhibit IκB protein phosphorylation [41].
Humulene. A source of monocyclic sesquiter-
pene humulene is Humulus lupulus, which is chemi-
cally α-caryophyllene. It was observed that activa-
tion of NF-κB system by LPS and the inflammatory 
response in rat paw edema assay could be effectively 
reduced by humulene. Even, it is more specific in prop-
erties, in comparison to other sesquiterpenes, as there 
is no modification in activation of extracellular signal 
regulated kinases (ERK), c-Jun N-terminal kinases 
(JNK) and p38 by humulene [42]..
Parthenolide. Parthenolide is known to be the 
most powerful NF-κB signaling inhibitor. Parthenolide 
inhibits nuclear translocation of p65 subunit and also 
inhibit DNA binding of NF-κB complex. It is also used 
in the treatment of arthritis and other inflammatory 
diseases [36, 43–45].
Helenalin A. Helenalin A is a sesquiterpene that 
inhibits NF-κB signaling. Helenalin alkylates p65 sub-
unit thus inhibiting the DNA binding of NF-κB complex. 
Table 3. Natural diterpenoids as inhibitors of NF-κB pathways
Name Structure Site of NF-κB inhibition Therapeutic Indication References
Acanthoic 
acid
CH3
COOHH3C
H
H
CH3
CH2 IκB phosphorylation Inflammation [42, 43]
Oridonin
OH
O
O
H3C
H
OH
OH
H
OH
CH3
DNA binding Leukemia,  immunosuppresion [44–46]
Taxol O
NHO
H3C
O
H3C
O
O
CH3
OH
O
O
OOH
CH3
CH3
O
CH3
O
O
OH
Degradation of IKK com-
plex Inflammation [47, 48]
Cornosol
CH3
O
O
HO
OH CH3
CH3H3C
H
IκBα phosphorylation Inflammation, metastasis [69, 70]
Ginkgolides
O
O
O
O
O
O
CH3
CH3
CH3
H3C
HO
OH
H
HO
O
H
DNA binding Neuroprotection,  inflammation [59, 71–73]
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In addition to its anti-inflammatory properties, this 
terpene is also potent against many infections [46, 47].
Ergolide. Ergolide comes under the category 
of sesquiterpenoid isolated from Innula britannica. 
Ergolide possesses anti-inflammatory and anticancer 
properties exerted via apoptosis induction. It inhibits 
translocation of NF-κB complex and degradation of IκB 
proteins [48, 49].
Zerumbone. It is a cyclic sesquiterpene isolated 
from Zingiber zerumbet. It induces phosphorylation 
of IκB proteins and thus blocks the function of IKK 
complex as a result of phosphorylation and degrada-
tion of IκB proteins. It leads to reduction of nuclear 
translocation of NF-κB complex [50, 51].
Valerenic acid. Valerenic acid is an effective ses-
quiterpene used against cancer and inflammation. 
Valerenic acid is obtained from Valeriana officinalis. 
It is a powerful inhibitor of NF-κB activation and cyto-
kine activation. It is also used in sleep disorders [52].
Diterpenoids. Diterpenoids (Table 3) are C20 com-
pounds, derived from four isoprene units and generally 
non-volatile in nature. They are biosynthesized from ge-
ranyl pyrophosphate. Diterpenoids may be acyclic, but 
generally they appear as monocyclic, bicyclic or tetracy-
clic compounds. Usually, diterpenoids show antitumor 
properties by indirectly inhibiting NF-κB signaling [22]. 
Some of the compounds with antitumor properties and 
of therapeutic importance are as follows:
Acanthoic acid. The mechanism of action of acan-
thoic acid and its analogues is reduction in activation 
of LPS induced IκBα phosphorylation along with inhibi-
tion of nuclear DNA binding of NF-κB system. Its prop-
erty to prevent cytokine synthesis and pro-inflammatory 
response was also revealed. Some studies reported the 
Table 4. Natural triterpenoids as inhibitors of NF-κB pathways
Name Structure Site of NF-κB inhibition Therapeutic Indication References
Ginsen-
osides
O
O
HO
O
O
H
HO
OH
HO
OH
H3C
CH3
HO
CH3
OH
H
H
H3C
H3C
HO
OH
H
H
CH3
OH
IκBα phosphorylation,  
and degradation
Neurodegenerative  
diseases, cancer, inflam-
mation
[50–53]
Glycyrrhizin
O
O
O
O
COOH
CH3
CH3
H3C
H3C
H
H3C
H
HCH3
O
COOH
HO
HO
HOOC
HO
OH
OH
DNA binding Inflammation [54–56]
Betulin
HO
CH3 CH3
H
H
H CH3
CH3
H2C
OH
H
H3C
H3C
IKKα inhibition Arthritis, cancer metas-tasis [74, 75]
Lupeol CH3
H
CH3CH3
HO
H CH3
H
3HC
CH2
CH33HC
IκBα phosphorylation Metastasis, skin cancer [76–78]
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ability of acanthoic acid to prevent fibrosis and nodular 
formation [53, 54].
Oridonin. Oridonin is a kaurane diterpenoid which 
is obtained from Rabsodia rubescens. Oridonin af-
fects the cancerous cells proliferation by inducing 
phagocytosis of apoptotic cells by macrophages and 
trigger apoptotic cell death as well. In vitro and in vivo 
studies have revealed immunosuppressive properties 
of oridonin. Unlike other diterpenoids, which suppress 
TNFα-induced IκBα protein degradation and nuclear 
translocation of NF-κB complex, oridonin inhibits 
NF-κB signaling by reversibly inhibiting DNA binding 
of NF-κB complex [55–57].
Taxol. Taxus brevifolia, a pacific yew tree, is a source 
of taxol which is chemically a complex polyoxygen-
ated diterpenoid. Paclitaxel (generic name of taxol) 
is a popu lar and powerful drug used in cancer che-
motherapy. The anticancer property of taxol is due 
to its binding to the β-tubulin protein present in mi-
crotubules. This results in suppression of microtu-
bular dynamics and it also raised acetylation level 
of α-tubulin protein. This increase in stability of micro-
tubules inhibits mitosis and thus results in cell death 
of proliferating cells. Some studies reveal the capacity 
of taxol in activation of NF-κB signaling via activation 
of TLR4 receptor (a receptor responsible for LPS in-
duced NF-κB signaling) by taxol. The binding of taxol 
to CD18 protein also activates TLR4 system [58, 59].
Cornosol. Cornosol is a diterpenoid, obtained from 
Rosmarinus officinalis that inhibits IκBα phosphoryla-
tion and iNOS and NO production. Cornosol inhibits 
NF-κB signaling via its antioxidant capacity [60, 61].
Ginkgolide is biological active diterpenoid extract-
ed from Ginkgo biloba. Ginkgolides inhibits the DNA 
binding of NF-κB complex and iNOS activation, and 
is therapeutically efficient in variety of inflammatory 
disorders [59, 62–65, 71–73].
Triterpenoids. Triterpenoids (Table 4) are formed 
by six isoprene units with 30 carbon atoms, and are 
structurally similar as steroidal compounds. Triterpe-
noids are present either in free state or as ester or gly-
cosides and are classified as tetracyclic and pentacyclic 
triterpenoids. Various triterpenoids exhibiting NF-κB in-
hibiting properties are listed below [66].
Ginsenosides. Ginsenosides are steroids chemi-
cally similar to triterpene saponins. These compounds 
are obtained from roots of Panax ginseng (Korean gin-
seng), Panax notoginseng (Chinese ginseng), Panax 
quinquefolium (American ginseng) and other species 
of perennial plant Panax. Ginsenosides are widely 
used therapeutically as anti-inflammatory and anti-
cancer agents and are also found useful in treatment 
of neurodegenerative disorders. Ginsenosides have 
many targets in cells and some studies have revealed 
their anti-cancer and anti-inflammatory activities via 
regulating signaling pathways. Inhibition of NF-κB sig-
naling may be direct or indirect, and it is due to sup-
pression of IκBα protein degradation as well as IKKα 
kinase activation. Some studies also showed the effect 
of ginsenosides in the DNA binding of NF-κB system. 
Ginsenosides also inhibit JNK pathway and AP-1 bind-
ing activity which shows that it can affect the upstream 
components of NF-κB signaling [67–70].
Glycyrrhizin. Glycyrrhizin is chemically a triterpe-
noid saponin glycoside and is widely used in Chinese 
and Egyptian medicine for treatment of cardiovascular, 
gastrointestinal and respiratory disorders. Glycyrrhizin 
is an active chemical constituent of licorice obtained 
from roots and stolons of Glycyrrhiza glabra. Glycyrrhi-
zin is chemically composed of glycyrrhizic acid. Glycyr-
rhizic acid is widely studied and is shown to be capable 
to inhibit NF-κB signaling. Studies have also revealed 
the ability of glycyrrhizic acid to inhibit glutamate in-
duced excitotoxicity in primary neurons and calcium 
mediated activation of NF-κB system [71–73].
Betulin is pentacyclic triterpenoid extracted from 
the bark of Betula alba. Derivatives of betulin are more 
therapeutically active against HIV and inflammation 
and act through inhibition of IKKα and NF-κB depen-
dent gene expression [74, 75].
Lupeol is very common terpenoid found in many 
fruits and vegetables. The structure of lupeol is penta-
cyclic. Lupeol exhibits anticancer property by inhibit-
ing NF-κB signaling including phosphorylation of IκB 
proteins [76–78].
Avicins are the plant stress metabolites obtained 
from the Acacia victoriae. Avicins inhibit DNA binding 
of NF-κB complex. Avicins do not affect degradation 
of IκB proteins [79].
Carotenoid tetraterpenoids. Carotenoid terpe-
noids (Table 5) are the pigmented tetrapenes contain-
ing eight isoprene units. These compounds are found 
to have antioxidative activity with therapeutic effects 
in cardiovascular disorders and osteoporosis; they also 
exhibit anticancer activity by regulating NF-κB signal-
ing pathway.
Lycopene is an acyclic tetraterpenoid that is most 
commonly found in human body. Major dietary source 
include tomato and other fruits. Lycopene has powerful 
antioxidant activity. Lycopene can inhibit NF-κB signal-
Table 5. Natural carotenoid tetraterpenoids as inhibitors of NF-κB pathways
Name Structure Site of NF-κB inhibition Therapeutic Indication References
Lycopene NF-kB translocation Inflammation [80–83]
β-Carotene IκBα degradation,  DNA binding Cancer, inflammation [84, 85]
Lutein
OH
HO
IκBα degradation Cataract, uveitis [86, 87]
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ing, nuclear translocation of NF-κB complex as well 
as its DNA binding [80–83].
β-Carotene. These compounds are the cyclic 
carotenes. β-Carotene is stored in liver and converted 
into vitamin A. β-Carotene suppresses LPS induced 
NF-κB signaling. It also degrades IκB protein and inhibits 
nuclear translocation of p65 subunit and DNA binding 
of NF-κB complex. β-Carotene by virtue of its proxidant 
characteristic inhibits cancer growth [84, 85].
Lutein is a cyclic tetraterpenoid present in fruits, 
vegetables and egg yolk. It inhibits nuclear localization 
of p65 subunits and IκBα protein degradation. It also 
inhibits activation of NF-κB signaling. Lutein pigment 
can protect from oxidative stress and cataract [86, 87].
conclusIon
Chemically diverse class of terpenoids represented 
with monoterpenoids, sesquiterpenoids, diterpenoids, 
sesterterpenoids, triterpenoids, tetraterpenoids and 
polyterpenoids, is capable to inhibit signaling via 
NF-κB pathway through different mechanisms, in par-
ticular, through IκB phosphorylation, DNA binding, 
p65 translocation etc. This provides promising pos-
sibilities for the use of terpenoids as NF-κB inhibitors 
from natural sources, for treatment of various human 
pathologies including cancer.
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